<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335021</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Returned Rate and Changed Patterns of Systemic Antibiotic Use in Ambulatory Care in Hungary after the Pandemic-A Longitudinal Ecological Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">848</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13090848</ELocationID><Abstract><AbstractText>The COVID-19 pandemic affected the epidemiology of infectious diseases and changed the operation of health care systems and health care seeking behavior. Our study aimed to analyze the utilization of systemic antibiotics in ambulatory care in Hungary after the COVID-19 pandemic and compare it to the period before COVID. We defined three periods (24 months each): Before COVID, COVID, and After COVID. Monthly trends in systemic antibiotic (J01) use were calculated using the WHO ATC-DDD index and expressed as DDD/1000 inhabitants/day (DID) and number of exposed patients per active agent. The data were further categorized by the WHO AWaRe classification. In the After COVID period, we detected almost the same (11.61 vs. 11.11 DID) mean monthly use of systemic antibiotics in ambulatory care compared to the Before COVID period. We observed a decrease in the seasonality index in the After COVID period (46.86% vs. 39.86%). In the After COVID period, the use of cephalosporins and quinolones decreased significantly, while in the case of macrolides, a significant increase was observed compared to the Before COVID period, with excessive azithromycin use (66,869 vs. 97,367 exposed patients). This study demonstrated significant changes in the pattern of ambulatory care antibiotic use in Hungary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hambalek</LastName><ForeName>Helga</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matuz</LastName><ForeName>Mária</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7877-2399</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzsa</LastName><ForeName>Roxána</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papfalvi</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacsa</LastName><ForeName>Róbert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engi</LastName><ForeName>Zsófia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csatordai</LastName><ForeName>Márta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soós</LastName><ForeName>Gyöngyvér</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajdú</LastName><ForeName>Edit</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2309-3532</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine Infectiology Unit, Albert Szent-Györgyi Health Centre, University of Szeged, Állomás Street 1-3, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csupor</LastName><ForeName>Dezső</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4088-3333</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benkő</LastName><ForeName>Ria</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8009-8962</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Albert Szent-Györgyi Health Centre, University of Szeged, Semmelweis Street 6, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ITM NKFIA TKP2021-EGA-32</GrantID><Agency>Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AWaRe classification</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DDD</Keyword><Keyword MajorTopicYN="N">DID</Keyword><Keyword MajorTopicYN="N">Hungary</Keyword><Keyword MajorTopicYN="N">after the pandemic</Keyword><Keyword MajorTopicYN="N">antibiotic utilization</Keyword><Keyword MajorTopicYN="N">antibiotics</Keyword><Keyword MajorTopicYN="N">outpatient sector</Keyword><Keyword MajorTopicYN="N">pattern</Keyword><Keyword MajorTopicYN="N">quality indicators</Keyword><Keyword MajorTopicYN="N">quality of use</Keyword><Keyword MajorTopicYN="N">trend</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335021</ArticleId><ArticleId IdType="pmc">PMC11429041</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13090848</ArticleId><ArticleId IdType="pii">antibiotics13090848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cassini A., Högberg L.D., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis. Lancet Infect. Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30605-4</ArticleId><ArticleId IdType="pmc">PMC6300481</ArticleId><ArticleId IdType="pubmed">30409683</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts N., Amann M., Ayeb-Karlsson S., Belesova K., Bouley T., Boykoff M., Byass P., Cai W., Campbell-Lendrum D., Chambers J., et al. The Lancet Countdown on Health and Climate Change: From 25 Years of Inaction to a Global Transformation for Public Health. Lancet. 2018;391:581–630. doi: 10.1016/S0140-6736(17)32464-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32464-9</ArticleId><ArticleId IdType="pubmed">29096948</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuz M., Soós G., Hajdú E., Papfalvi E., Visnyovszki Á., Viola R., Benkő R. The characteristics and trends of Hungarian outpatient antibiotic use (2010–2019) Orv. Hetil. 2022;163:140–149. doi: 10.1556/650.2022.32324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/650.2022.32324</ArticleId><ArticleId IdType="pubmed">35066490</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins R.R., Bonomo R.A. Overview: The Ongoing Threat of Antimicrobial Resistance. Infect. Dis. Clin. N. Am. 2020;34:649–658. doi: 10.1016/j.idc.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2020.04.002</ArticleId><ArticleId IdType="pubmed">33011053</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J., Broughan J., Crowley D., O’Kelly B., Fawsitt R., Burke M.C., McCombe G., Lambert J.S., Cullen W. COVID-19’s Impact on Primary Care and Related Mitigation Strategies: A Scoping Review. Eur. J. Gen. Pract. 2021;27:166–175. doi: 10.1080/13814788.2021.1946681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13814788.2021.1946681</ArticleId><ArticleId IdType="pmc">PMC8293960</ArticleId><ArticleId IdType="pubmed">34282695</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden N.M.K., Mandil A.M.A., Hegazy A.A., Nagy N., Mabry R.M., Khairy W.A. Health Innovations in Response to the COVID-19 Pandemic: Perspectives from the Eastern Mediterranean Region. J. Public Health. 2023;45:470–480. doi: 10.1093/pubmed/fdac113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdac113</ArticleId><ArticleId IdType="pmc">PMC9620347</ArticleId><ArticleId IdType="pubmed">36310503</ArticleId></ArticleIdList></Reference><Reference><Citation>Walia K., Mendelson M., Kang G., Venkatasubramanian R., Sinha R., Vijay S., Veeraraghavan B., Basnyat B., Rodrigues C., Bansal N., et al. How Can Lessons from the COVID-19 Pandemic Enhance Antimicrobial Resistance Surveillance and Stewardship? Lancet Infect. Dis. 2023;23:e301–e309. doi: 10.1016/S1473-3099(23)00124-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00124-X</ArticleId><ArticleId IdType="pubmed">37290476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurdi A., Al Mutairi N., Baker K., M-Amen K., Darweesh O., Karwi H., Seaton A., Sneddon J., Godman B. Impact of COVID-19 Pandemic on the Utilization and Quality of Antibiotic Use in the Primary Care Setting in England, March 2019–March 2023: A Segmented Interrupted Time Series Analysis of over 53 Million Individuals. Expert Rev. Anti-Infect. Ther. 2024:1–12. doi: 10.1080/14787210.2024.2368816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2024.2368816</ArticleId><ArticleId IdType="pubmed">38940069</ArticleId></ArticleIdList></Reference><Reference><Citation>Coenen S., Ferech M., Haaijer-Ruskamp F.M., Butler C.C., Vander Stichele R.H., Verheij T.J.M., Monnet D.L., Little P., Goossens H. ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): Quality Indicators for Outpatient Antibiotic Use in Europe. Qual. Saf. Health Care. 2007;16:440–445. doi: 10.1136/qshc.2006.021121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2006.021121</ArticleId><ArticleId IdType="pmc">PMC2653179</ArticleId><ArticleId IdType="pubmed">18055888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-Gabarró C., Leung V.H., Vlahović-Palčevski V., Machowska A., Monnet D.L., Högberg L.D., Group E.-N. study Rebound in Community Antibiotic Consumption after the Observed Decrease during the COVID-19 Pandemic, EU/EEA, 2022. Eurosurveillance. 2023;28:2300604. doi: 10.2807/1560-7917.ES.2023.28.46.2300604.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.46.2300604</ArticleId><ArticleId IdType="pmc">PMC10655206</ArticleId><ArticleId IdType="pubmed">37971660</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrobial Consumption in the EU/EEA (ESAC-Net)—Annual Epidemiological Report for 2022.  [(accessed on 4 July 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2022.</Citation></Reference><Reference><Citation>King L.M., Lovegrove M.C., Shehab N., Tsay S., Budnitz D.S., Geller A.I., Lind J.N., Roberts R.M., Hicks L.A., Kabbani S. Trends in US Outpatient Antibiotic Prescriptions During the Coronavirus Disease 2019 Pandemic. Clin. Infect. Dis. 2021;73:e652–e660. doi: 10.1093/cid/ciaa1896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1896</ArticleId><ArticleId IdType="pmc">PMC7799289</ArticleId><ArticleId IdType="pubmed">33373435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitano T., Brown K.A., Daneman N., MacFadden D.R., Langford B.J., Leung V., So M., Leung E., Burrows L., Manuel D., et al. The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis. Open Forum Infect. Dis. 2021;8:ofab533. doi: 10.1093/ofid/ofab533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab533</ArticleId><ArticleId IdType="pmc">PMC8601042</ArticleId><ArticleId IdType="pubmed">34805442</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva T.M., Estrela M., Gomes E.R., Piñeiro-Lamas M., Figueiras A., Roque F., Herdeiro M.T. The Impact of the COVID-19 Pandemic on Antibiotic Prescribing Trends in Outpatient Care: A Nationwide, Quasi-Experimental Approach. Antibiotics. 2021;10:1040. doi: 10.3390/antibiotics10091040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10091040</ArticleId><ArticleId IdType="pmc">PMC8465975</ArticleId><ArticleId IdType="pubmed">34572622</ArticleId></ArticleIdList></Reference><Reference><Citation>Colliers A., De Man J., Adriaenssens N., Verhoeven V., Anthierens S., De Loof H., Philips H., Coenen S., Morreel S. Antibiotic Prescribing Trends in Belgian Out-of-Hours Primary Care during the COVID-19 Pandemic: Observational Study Using Routinely Collected Health Data. Antibiotics. 2021;10:1488. doi: 10.3390/antibiotics10121488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10121488</ArticleId><ArticleId IdType="pmc">PMC8698421</ArticleId><ArticleId IdType="pubmed">34943701</ArticleId></ArticleIdList></Reference><Reference><Citation>Högberg L.D., Vlahović-Palčevski V., Pereira C., Weist K., Monnet D.L., ESAC-Net study group ESAC-Net study group participants Decrease in Community Antibiotic Consumption during the COVID-19 Pandemic, EU/EEA, 2020. Eurosurveillance. 2021;26:2101020. doi: 10.2807/1560-7917.ES.2021.26.46.2101020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.46.2101020</ArticleId><ArticleId IdType="pmc">PMC8603403</ArticleId><ArticleId IdType="pubmed">34794534</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrobial Consumption—Annual Epidemiological Report for 2019.  [(accessed on 4 July 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2019.</Citation></Reference><Reference><Citation>Antimicrobial Consumption in the EU/EEA (ESAC-Net)—Annual Epidemiological Report for 2020.  [(accessed on 4 July 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2020.</Citation></Reference><Reference><Citation>Antimicrobial Consumption in the EU/EEA (ESAC-Net)—Annual Epidemiological Report for 2021.  [(accessed on 4 July 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2021.</Citation></Reference><Reference><Citation>The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book. World Health Organization; Geneva, Switzerland: 2022.</Citation></Reference><Reference><Citation>AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use, 2023.  [(accessed on 4 July 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04.</Citation></Reference><Reference><Citation>WHO Antibiotics Portal.  [(accessed on 4 July 2024)].  Available online:  https://aware.essentialmeds.org/groups.</Citation></Reference><Reference><Citation>Adriaenssens N., Bruyndonckx R., Versporten A., Hens N., Monnet D.L., Molenberghs G., Goossens H., Weist K., Coenen S. Quality Appraisal of Antibiotic Consumption in the Community, European Union/European Economic Area, 2009 and 2017. J. Antimicrob. Chemother. 2021;76:ii60–ii67. doi: 10.1093/jac/dkab178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkab178</ArticleId><ArticleId IdType="pmc">PMC8314110</ArticleId><ArticleId IdType="pubmed">34312656</ArticleId></ArticleIdList></Reference><Reference><Citation>The Correct Use of Antimicorbal Agents [Hungarian]  [(accessed on 7 July 2024)].  Available online:  https://efop180.antsz.hu/tajekoztatok/modszertani-anyagok/144-antimikrobas-szerek-helyes-hasznalata.html.</Citation></Reference><Reference><Citation>Hambalek H., Matuz M., Ruzsa R., Engi Z., Visnyovszki Á., Papfalvi E., Hajdú E., Doró P., Viola R., Soós G., et al. Impact of the COVID-19 Pandemic on Ambulatory Care Antibiotic Use in Hungary: A Population-Based Observational Study. Antibiotics. 2023;12:970. doi: 10.3390/antibiotics12060970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12060970</ArticleId><ArticleId IdType="pmc">PMC10294918</ArticleId><ArticleId IdType="pubmed">37370289</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitális E. Management of Otitis in Outpatient Care; Version 1; Prepared by the Methodological Development Working Group I. of the EFOP 1.8.0-VEKOP-17-2017-00001 Project “Professional Methodological Development of the Healthcare System”. [hungarian] 2020.  [(accessed on 4 July 2024)].  Available online:  https://info.nevesforum.hu/wp-content/uploads/2021/03/otitis.pdf.</Citation></Reference><Reference><Citation>Vitális E. Management of Sinusitis in Outpatient Care; Version 1; Prepared by the Methodological Development Working Group I. of the EFOP 1.8.0-VEKOP-17-2017-00001 Project “Professional Methodological Development of the Healthcare System” [hungarian] 2020.  [(accessed on 4 July 2024)].  Available online:  https://info.nevesforum.hu/wp-content/uploads/2021/03/sinusitis.pdf.</Citation></Reference><Reference><Citation>Hajdú E., Szabó É. Home-Acquired Pneumonia Antimicrobial Treatment in Outpatient Care; Version 1; Prepared by the Methodological Development Working Group I of the EFOP 1.8.0-VEKOP-17-2017-00001 Project “Professional Methodological Development of the Healthcare System”. [Hungarian] 2020.  [(accessed on 4 July 2024)].  Available online:  https://info.nevesforum.hu/wp-content/uploads/2021/03/pneumonia.pdf.</Citation></Reference><Reference><Citation>National Bacteriological Surveillance 2022 (NBS)  [(accessed on 14 August 2024)]; Available online:  https://www.nnk.gov.hu/index.php/mikrobiologiai-referencia-laboratoriumi-foosztaly/nemzeti-bakteriologiai-surveillance-nbs/category/347-nemzeti-bakteriologiai-surveillance-2022.html.</Citation></Reference><Reference><Citation>WHO Model List of Essential Medicines—23rd List, 2023.  [(accessed on 4 July 2024)].  Available online:  https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02.</Citation></Reference><Reference><Citation>Benkő R. Guidelines for the Antibacterial Treatment of Acute Sore Throat (Tonsillopharyngitis) in Outpatient Care; Version 1; Prepared by the Methodological Development Working Group I. of the EFOP 1.8.0-VEKOP-17-2017-00001 Project “Professional Methodological Development of the Healthcare System” [hungarian] 2020.  [(accessed on 4 July 2024)].  Available online:  https://info.nevesforum.hu/wp-content/uploads/2021/03/torokfajas.pdf.</Citation></Reference><Reference><Citation>Szabó B.G. Antibiotic Treatment of Uncomplicated Acute Pyelonephritis in Outpatient Care; Version 1; Prepared by the Methodological Development Working Group I of the EFOP 1.8.0-VEKOP-17-2017-00001 Project “Professional Methodological Development of the Healthcare System”. [hungarian] 2020.  [(accessed on 4 July 2024)].  Available online:  https://info.nevesforum.hu/wp-content/uploads/2021/03/cystitis.pdf.</Citation></Reference><Reference><Citation>Fluoroquinolone and Quinolone Antibiotics: PRAC Recommends New Restrictions on Use Following Review of Disabling and Potentially Long-Lasting Side Effects|European Medicines Agency.  [(accessed on 7 July 2024)].  Available online:  https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrictions-use-following-review-disabling-potentially-long-lasting-side-effects.</Citation></Reference><Reference><Citation>Pharmacovigilance Risk Assessment Committee (PRAC): 10–12 May 2023|European Medicines Agency.  [(accessed on 4 July 2024)].  Available online:  https://www.ema.europa.eu/en/events/pharmacovigilance-risk-assessment-committee-prac-10-12-may-2023.</Citation></Reference><Reference><Citation>Fluoroquinolone Antibiotics: Reminder of Measures to Reduce the Risk of Long-Lasting, Disabling and Potentially Irreversible Side Effects|European Medicines Agency.  [(accessed on 3 July 2024)].  Available online:  https://www.ema.europa.eu/en/news/fluoroquinolone-antibiotics-reminder-measures-reduce-risk-long-lasting-disabling-potentially-irreversible-side-effects.</Citation></Reference><Reference><Citation>Increase of Pertussis Cases in the EU/EEA.  [(accessed on 22 July 2024)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/increase-pertussis-cases-eueea.</Citation></Reference><Reference><Citation>Antibiotic Utilisation Data.  [(accessed on 3 July 2024)]; Available online:  https://www.neak.gov.hu/felso_menu/szakmai_oldalak/publikus_forgalmi_adatok/gyogyszer_forgalmi_adatok/gyogyszer_forgalmi_adatok.</Citation></Reference><Reference><Citation>ATCDDD—ATC/DDD Index.  [(accessed on 4 July 2024)].  Available online:  https://atcddd.fhi.no/atc_ddd_index/?code=J01&amp;showdescription=no.</Citation></Reference><Reference><Citation>Hollingworth S., Kairuz T. Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data. Pharmacy. 2021;9:60. doi: 10.3390/pharmacy9010060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmacy9010060</ArticleId><ArticleId IdType="pmc">PMC8006033</ArticleId><ArticleId IdType="pubmed">33802774</ArticleId></ArticleIdList></Reference><Reference><Citation>Hungarian Central Statistical Office Information Data Base. Population. Population Movement. KSH. Main Indicators of Population and Vital Events (1941–2024)  [(accessed on 4 July 2024)].  Available online:  https://www.ksh.hu/stadat_eng?lang=en&amp;theme=nep.</Citation></Reference><Reference><Citation>Goossens H., Ferech M., Vander Stichele R., Elseviers M. Outpatient Antibiotic Use in Europe and Association with Resistance: A Cross-National Database Study. Lancet. 2005;365:579–587. doi: 10.1016/S0140-6736(05)17907-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)17907-0</ArticleId><ArticleId IdType="pubmed">15708101</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriaenssens N., Coenen S., Versporten A., Muller A., Vankerckhoven V., Goossens H., ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): Quality Appraisal of Antibiotic Use in Europe. J. Antimicrob. Chemother. 2011;66((Suppl. 6)):vi71–vi77. doi: 10.1093/jac/dkr459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkr459</ArticleId><ArticleId IdType="pubmed">22096068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>